DDW_InFocus_Report_Neuroscience_FrontCover with shadow_400px

The global prevalence of dementia is approximately 24 million, and is predicted to double every 20 years until at least 2040. Currently, no medications can cure this, though 2024 has proved to be a poignant year of developments in neuroscience, especially considering the challenges faced in previous decades. This guide showcases the potential within drug discovery. 

Download this In Focus eReport to learn more about the drug discovery innovation and advancement taking place in this field.

The eReport includes:

  • A global market overview including prevalence, value and future outlook
  • A scientific article on developing therapeutics targeting biomolecular condensates
  • An interview with ApconiX’s Director and Co-founder, Professor Ruth Roberts, and Scientific Lead, Kimberly Rockley
  • An exploration of the new frontiers in neuroscience

Sponsored by 

APPROVED APCONIX LOGO 2017_RGB_220px

 

Download the e-report